Diabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world settingCapsule Summary
Introduction: Patients with psoriasis and psoriatic arthritis have a higher prevalence of cardiometabolic comorbidities compared to the general population. Clinical data suggest apremilast may reduce weight and glycated hemoglobin (HbA1c). Objective: To describe changes in cardiometabolic parameters...
Saved in:
Main Authors: | Cristi Cavanaugh, MHS (Author), Kate Orroth, PhD, MPH (Author), Xi Qian, PhD (Author), Pam Kumparatana, MSW, MPH (Author), Yuri Klyachkin, PhD (Author), Stephen Colgan, PhD (Author), Myriam Cordey, PhD, MPH (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
by: Dafna D. Gladman, MD, et al.
Published: (2020) -
Androgenetic alopecia: An updateCapsule Summary
by: Sincengile Ntshingila, PhD, et al.
Published: (2023) -
Societal impact for patients with psoriasis: A nationwide Swedish register studyCapsule Summary
by: Henrike Häbel, PhD, et al.
Published: (2021) -
Self-Rated Health Status Based on the Type of Health Insurance: A Socioeconomic Perspective
by: Minsung Sohn PhD, MPH, et al.
Published: (2021) -
Challenges to Admitting Residents: Perspectives from Rural Nursing Home Administrators and Staff
by: Carrie Henning-Smith PhD, MPH, MSW, et al.
Published: (2021)